Clinical Utility of the Apolipoprotein <scp>A2</scp> Isoform Index as a Tumor Marker for Pancreatic Cancer

20260 citationsJournal Articlegold Open Access

Authors

Takashi Hoshino · National Hospital Organization Takasaki Medical Center

Masafumi Mizuide · Saitama Medical University

Yuhei Suzuki · National Hospital Organization Takasaki Medical Center

Hidetoshi Yasuoka · National Hospital Organization Takasaki Medical Center

Atsushi Naganuma · National Hospital Organization Takasaki Medical Center

Takeshi Hatanaka · Gunma Saiseikai Maebashi Hospital

Abstract

The apoA2-i index can detect CA19-9-negative pancreatic cancer, and the combination of the apoA2-i index with CA19-9 enhances diagnostic performance in clinical practice.

Topics & Keywords

Cancer, Lipids, and Metabolism Lipoproteins and Cardiovascular Health Clusterin in disease pathology

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JGH Open

Volume 10, Issue 3, pp. e70375-e70375

DOI: 10.1002/jgh3.70375

Field-Weighted Citation Impact: 0.00